- Home
- NE vs HAE Comparison
NE vs HAE Comparison
Compare NE & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NE
- HAE
- Stock Information
- Founded
- NE 1985
- HAE 1971
- Country
- NE United States
- HAE United States
- Employees
- NE N/A
- HAE N/A
- Industry
- NE Other Specialty Stores
- HAE Medical/Dental Instruments
- Sector
- NE Consumer Discretionary
- HAE Health Care
- Exchange
- NE Nasdaq
- HAE Nasdaq
- Market Cap
- NE 3.5B
- HAE 3.3B
- IPO Year
- NE N/A
- HAE 1991
- Fundamental
- Price
- NE $30.27
- HAE $52.21
- Analyst Decision
- NE Buy
- HAE Buy
- Analyst Count
- NE 8
- HAE 10
- Target Price
- NE $33.14
- HAE $84.20
- AVG Volume (30 Days)
- NE 2.1M
- HAE 945.0K
- Earning Date
- NE 11-04-2025
- HAE 11-06-2025
- Dividend Yield
- NE 6.61%
- HAE N/A
- EPS Growth
- NE N/A
- HAE 46.89
- EPS
- NE 1.94
- HAE 3.28
- Revenue
- NE $3,290,137,000.00
- HAE $1,346,046,000.00
- Revenue This Year
- NE $15.25
- HAE N/A
- Revenue Next Year
- NE N/A
- HAE $6.50
- P/E Ratio
- NE $15.62
- HAE $15.93
- Revenue Growth
- NE 28.85
- HAE 0.91
- 52 Week Low
- NE $17.40
- HAE $50.68
- 52 Week High
- NE $37.99
- HAE $94.99
- Technical
- Relative Strength Index (RSI)
- NE 64.00
- HAE 30.00
- Support Level
- NE $29.70
- HAE $53.10
- Resistance Level
- NE $30.75
- HAE $54.52
- Average True Range (ATR)
- NE 0.92
- HAE 1.22
- MACD
- NE 0.22
- HAE 0.53
- Stochastic Oscillator
- NE 76.11
- HAE 7.61
About NE Noble Corporation plc A
Noble Corp PLC is an offshore drilling contractor for the oil and gas industry that provides contract drilling services to the international oil and gas industry with its fleet of mobile offshore drilling units. The company focuses on a high-specification fleet of floating and jackup rigs and the deployment of its drilling rigs in oil and gas basins around the world.
About HAE Haemonetics Corporation
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.